C-kit gene abnormalities in gastrointestinal stromal tumors (tumors of interstitial cells of Cajal. - Wikidata - awgldk - TriplyDB

C-kit gene abnormalities in gastrointestinal stromal tumors (tumors of interstitial cells of Cajal.

C-kit gene abnormalities in gastrointestinal stromal tumors (tumors of interstitial cells of Cajal.

http://www.wikidata.org/entity/Q43848730

about

A great majority of GISTs with PDGFRA mutations represent gastric tumors of low or no malignant potential.The complexity of KIT gene mutations and chromosome rearrangements and their clinical correlation in gastrointestinal stromal (pacemaker cell) tumors The histopathological differential diagnosis of gastrointestinal stromal tumours Malignant gastrointestinal stromal tumor of the gallbladder.Prognostic value of KIT/PDGFRA mutations in gastrointestinal stromal tumors: a meta-analysis.Tyrosine kinases and gastric cancer.Neoplasms associated with germline and somatic NF1 gene mutations Targeting G-quadruplexes in gene promoters: a novel anticancer strategy?Gastrointestinal stromal tumors.Allelic loss of 14q and 22q, NF2 mutation, and genetic instability occur independently of c-kit mutation in gastrointestinal stromal tumor.Surgery and imatinib in the management of GIST: emerging approaches to adjuvant and neoadjuvant therapy.Gastrointestinal stromal tumors: from a surgical to a molecular approach.Gastrointestinal stromal tumors: a paradigm for molecularly targeted therapy.The location of KIT and PDGFRA gene mutations in gastrointestinal stromal tumours is site and phenotype associated.Mutations in exons 9 and 13 of KIT gene are rare events in gastrointestinal stromal tumors. A study of 200 cases Germline-activating mutation in the kinase domain of KIT gene in familial gastrointestinal stromal tumors Molecular characterisation of gastrointestinal stromal tumours in a South African population Neoadjuvant, adjuvant and palliative treatment of gastrointestinal stromal tumours (GIST) with imatinib: a centre-based study of 17 patients.Large gastrointestinal stromal tumor size does not imply early recurrence Structures, folding patterns, and functions of intramolecular DNA G-quadruplexes found in eukaryotic promoter regions.Clinical significance of oncogenic KIT and PDGFRA mutations in gastrointestinal stromal tumours.Kinase inhibitors in cancer therapy.Gastrointestinal stromal tumors: molecular mechanisms and targeted therapies.Gastrointestinal (GI) leiomyosarcoma (LMS) case series and review on diagnosis, management, and prognosis.Combined KIT and CTLA-4 Blockade in Patients with Refractory GIST and Other Advanced Sarcomas: A Phase Ib Study of Dasatinib plus Ipilimumab.A meta-analysis of prognostic value of KIT mutation status in gastrointestinal stromal tumors Thy-1 as a potential novel diagnostic marker for gastrointestinal stromal tumors.Gain-of-Function Mutations of Receptor Tyrosine Kinases in Gastrointestinal Stromal Tumors.Microfluidic deletion/insertion analysis for rapid screening of KIT and PDGFRA mutations in CD117-positive gastrointestinal stromal tumors: diagnostic applications and report of a new KIT mutation.A conserved quadruplex motif located in a transcription activation site of the human c-kit oncogene.Selective recognition of a DNA G-quadruplex by an engineered antibody.G-quadruplex-binding benzo[a]phenoxazines down-regulate c-KIT expression in human gastric carcinoma cells.c-kit gene mutation at exon 17 or 13 is very rare in sporadic gastrointestinal stromal tumors.Alterations of the c-kit gene in testicular germ cell tumors.Deletion of Trp-557 and Lys-558 in the juxtamembrane domain of the c-kit protooncogene is associated with metastatic behavior of gastrointestinal stromal tumors.c-kit gene mutations in intracranial germinomas.Reappraisal of KIT mutation in adenoid cystic carcinomas of the salivary gland.The cyclin-dependent kinase inhibitor, p27, has no correlation with the malignant potential of GIST.Gastrointestinal stromal tumor with dedifferentiation to undifferentiated pleomorphic sarcoma.Mutations in c-kit gene exons 9 and 13 in gastrointestinal stromal tumors among Japanese.

P2860

Q27824814-2E30CC58-0DCF-4B6B-A3EA-C9E73B85DB89 Q28344793-81D2F103-A4E0-43CD-BF47-DF68869B744C Q28352810-3DDF3D7B-7839-47F0-ADE8-8A3DB0F26E38 Q33629772-1F8B3F81-9C7D-43D3-913A-B7F967B095B4 Q33712862-47C095C8-8057-40D6-9599-12861A1D68F6 Q34103663-16FBEBF3-AF37-45D1-8791-216C0484F483 Q34125947-8E5E0D73-E70E-4735-BAFB-3314C31CCB20 Q34174883-901EE300-1A8D-4415-95DE-48A626951790 Q34265279-E60FBA2E-E319-4B5D-9B85-89BF45FCBE25 Q34512501-B602B15E-51AE-4AC7-8B00-F9B96756704A Q34547563-4A90F9CF-72B7-4FA5-A5D5-4D43F93DECA4 Q35209537-AE01E695-DF30-4314-9FA4-DC481BC7C556 Q35553853-F4C3533A-E8B3-448E-BA3A-6CA450A77CE7 Q35588633-ECFC5F38-F6CB-4710-B38C-4A4EBE0B5881 Q35745870-9916FA31-2F97-4A5A-8B37-EE9EF426C753 Q35829580-2A8256EE-738F-44AB-A543-AB98683BAD37 Q36475766-5C08A4FE-553F-4C01-A9E6-6EE175BF2F66 Q36671415-BA251BFC-A493-4FD9-A47B-E725A6CAE277 Q36856506-2AEF8E90-906F-4BDD-9A3A-2ADF49E88188 Q36978525-7608DB4A-B089-4298-B6DE-73D642333CE4 Q37099095-B0D9C9D6-9BF9-4F18-8201-7420D1D4CAD3 Q37451719-08CA9068-C9B3-4F37-A55F-54EB3A2EC173 Q37874125-B591AC95-D74C-42F1-86A1-A43E04A93242 Q38703103-738E9D11-9F9A-4CF8-A2F7-DFC7ED202B74 Q39070576-D5A821F3-B5C2-4DD1-B0EF-F723DD814562 Q39650027-6925E2A1-CAC0-4663-A359-010AC7BF737E Q40208940-08B22D49-3C22-4BDA-B84C-0A1795DD9D42 Q41852979-66DEED99-543A-4C01-9CA7-F57129B4493C Q41901975-B76A13CC-CE2B-4027-8339-1E464BE5CA57 Q42108961-7C6B25B6-7492-4540-A079-9B9F78E9FC85 Q42559983-55663439-299D-4682-B5FE-4153BF3F4458 Q42785249-3710C435-1E6F-44A9-8763-9C34F61C6B84 Q44287763-18195E49-144A-4B36-8693-859AF9039546 Q44490297-CE2ECED8-1AE3-4FC3-B287-97D6D5BDD621 Q44549290-23D501B2-C733-4483-B4E3-04AE0BEFB589 Q45095957-E3A8571A-220B-44CF-9549-459DA350ADD6 Q53398917-22C44F87-D2CE-472B-85BC-1C850C5C3960 Q53561823-29D05292-4C82-4709-B530-423FAA8247AB Q54648663-14C1EA22-810A-4B9E-8AB2-5EB43822FA08 Q55246254-A280592A-E212-41F5-9FE5-B1B882343374

P2860

C-kit gene abnormalities in gastrointestinal stromal tumors (tumors of interstitial cells of Cajal.

http://www.wikidata.org/entity/Q43848730

description

1999 nî lūn-bûn

@nan

1999年の論文

@ja

1999年学术文章

@wuu

1999年学术文章

@zh

1999年学术文章

@zh-cn

1999年学术文章

@zh-hans

1999年学术文章

@zh-my

1999年学术文章

@zh-sg

1999年學術文章

@yue

1999年學術文章

@zh-hant

name

C-kit gene abnormalities in ga ...... f interstitial cells of Cajal.

@en

C-kit gene abnormalities in gastrointestinal stromal tumors

@nl

type

label

C-kit gene abnormalities in ga ...... f interstitial cells of Cajal.

@en

C-kit gene abnormalities in gastrointestinal stromal tumors

@nl

prefLabel

C-kit gene abnormalities in ga ...... f interstitial cells of Cajal.

@en

C-kit gene abnormalities in gastrointestinal stromal tumors

@nl

P1433

Q43848730-A78AE019-A700-4128-B537-6C81AF0F9247

P1476

Q43848730-37EAA5F6-9739-43BE-9D94-D28BD62100B1

P2093

Q43848730-1CA8FFF7-A41E-480D-A117-4C20D1A5F94B

Q43848730-7DF61FF7-7FDC-453D-B5A1-8EE10DEEBA19

Q43848730-A757A39D-BC9F-4789-9762-8DF9EC6F1890

Q43848730-AAA8C064-2DCF-4D3C-A862-19AE79DF6480

Q43848730-D3DCB141-8D37-40DD-8B91-00B99A84FFFC

P2860

Q43848730-0DDBE57F-BA5B-428E-A096-50A01AF64B21

Q43848730-0F16F74A-8EF0-4B2D-8C93-4FB95572CAAF

Q43848730-0FF9776C-F364-4320-89AA-13A240C91AA2

Q43848730-3FF9D994-D7DC-4B77-95E3-29C734B33FD2

Q43848730-54BFB3DE-81B6-41C5-A6A1-8E7F93B829AC

Q43848730-54C7B555-F482-497E-89C8-B32D2B379C71

Q43848730-A99EBE8A-8CE5-4DF3-B31C-62EEB5808380

Q43848730-B46C2C3E-FD08-46EB-8EE9-217C228EF4C0

Q43848730-D1E7A0E4-C7C7-4151-B817-E72FBCF74BF3

Q43848730-F052FAB3-41C3-4FEF-BDAD-7057C563387E

P304

Q43848730-C9F92B09-28D7-4568-89D8-C90639BE0D44

P31

Q43848730-13207158-062E-428E-953A-B6842B40AAC9

P356

Q43848730-0422BD3C-1795-4FB6-90EC-76BDAC56945B

P433

Q43848730-F234E7E4-43E9-4568-B0D4-D2DE8796C27F

P478

Q43848730-3795F4B6-078A-48AF-ABAB-F6F20CC426B0

P577

Q43848730-3A316BB3-277D-42F0-9742-1E65BDAE707D

P5875

Q43848730-4DA2D7D1-5FBC-447B-B0B7-6589D6DDEF68

P698

Q43848730-843E832D-8E48-4DE3-8039-29DAF1963B2D

P932

Q43848730-C5C9F6DE-C7C5-4BE7-8A7F-CDD133E851A3

P356

J.1349-7006.1999.TB00715.X

P1433

Japanese Journal of Cancer Research

P1476

C-kit gene abnormalities in ga ...... f interstitial cells of Cajal.

@en

P2093

A Tanaka

http://www.w3.org/2001/XMLSchema#string

J M Chong

http://www.w3.org/2001/XMLSchema#string

M Fukayama

http://www.w3.org/2001/XMLSchema#string

S Sakurai

http://www.w3.org/2001/XMLSchema#string

T Fukasawa

http://www.w3.org/2001/XMLSchema#string

P2860

Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors

Mutations of c-kit JM domain are found in a minority of human gastrointestinal stromal tumors.

Muscle differentiation and clinicopathologic features of gastrointestinal stromal tumors.

Disturbed intestinal movement, bile reflux to the stomach, and deficiency of c-kit-expressing cells in Ws/Ws mutant rats.

W/kit gene required for interstitial cells of Cajal and for intestinal pacemaker activity.

Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal.

Embryonic form of smooth muscle myosin heavy chain (SMemb/MHC-B) in gastrointestinal stromal tumor and interstitial cells of Cajal

Mutations in exon 11 of c-Kit occur preferentially in malignant versus benign gastrointestinal stromal tumors and do not occur in leiomyomas or leiomyosarcomas.

A novel gain-of-function mutation of c-kit gene in gastrointestinal stromal tumors.

Pacemaker cells in the gastrointestinal tract: interstitial cells of Cajal.

P304

1321-1328

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1349-7006.1999.TB00715.X

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

90

http://www.w3.org/2001/XMLSchema#string

P577

1999-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12648981

http://www.w3.org/2001/XMLSchema#string

P698

10665649

http://www.w3.org/2001/XMLSchema#string

P932

5926026

http://www.w3.org/2001/XMLSchema#string